Stable isotope dilution multidimensional liquid chromatography-tandem mass spectrometry for pancreatic cancer serum biomarker discovery

Journal of Proteome Research

Volumn 8, Issue 3, 2009, Pages 1565-1576

  Yu, Kenneth H ^a   Barry, Colin G ^a   Austin, David ^a   Busch, Christine M ^a   Sangar, Vineet ^a   Rustgi, Anil K ^a   Blair, Ian A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Pancreatic cancer; Serum biomarkers; SILAC

Indexed keywords

ACTIN RELATED PROTEIN 2-3 COMPLEX; ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; AMINO ACID; AMINOACYLASE; ASPARTATE AMINOTRANSFERASE ISOENZYME 1; BASAL CELL ADHESION MOLECULE; CALVASCULIN; CARBONATE DEHYDRATASE I; CATALASE; CATHEPSIN D; CENTROMERE PROTEIN E; CHAPERONIN; CYTOKERATIN 18; CYTOKERATIN 8; DIPEPTIDYL PEPTIDASE I; DOPACHROME TAUTOMERASE; FILAMIN A; INTERCELLULAR ADHESION MOLECULE 1; MATRILYSIN; MOESIN; OSTEONECTIN; OXYGEN REGULATED PROTEIN 150; PEROXIREDOXIN 6; PHOSPHATIDYLETHANOLAMINE BINDING PROTEIN; PYRIDOXAL KINASE; RYANODINE RECEPTOR 3; STABLE ISOTOPE; TUMOR MARKER; UBIQUITIN CONJUGATING ENZYME E2; UNCLASSIFIED DRUG; VINCULIN;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; ISOELECTRIC FOCUSING; ISOTOPE DILUTION ASSAY; ISOTOPE LABELING; LIQUID CHROMATOGRAPHY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN SECRETION; TANDEM MASS SPECTROMETRY; WESTERN BLOTTING;

ADULT; AGED; AGED, 80 AND OVER; CELL LINE, TUMOR; CHROMATOGRAPHY, LIQUID; EARLY DETECTION OF CANCER; FEMALE; HUMANS; ISOTOPE LABELING; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 65249113798     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr800904z     Document Type: Article

References (47)

1. Niederhuber, J. E.; Brennan, M. F.; Menck, H. R. The National Cancer Data Base report on pancreatic cancer. Cancer 1995, 76, 1671-1677.
2. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58, 71-96.
3. Abrams, R. A.; Grochow, L. B.; Chakravarthy, A.; Sohn, T. A.; Zahurak, M. L.; Haulk, T. L.; Ord, S.; Hruban, R. H.; Lillemoe, K. D.; Pitt, H. A.; Cameron, J. L.; Yeo, C. J. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy doseand CA19-9 levels. Int. J.Radiat. Oncol. Biol. Phys. 1999, 44, 10391046.
4. Ritts, R. E.; Pitt, H. A. CA 19-9 in pancreatic cancer. Surg. Oncol. Clin. N. Am. 1998, 7, 93-101.
5. Furuya, N.; Kawa, S.; Hasebe, O.; Tokoo, M.; Mukawa, K.; Maejima, S.; Oguchi, H. Comparative study of CA242 and CA19-9 in chronic pancreatitis. Br. J. Cancer 1996, 73, 372-376.
6. Albert, M. B.; Steinberg, W. M.; Henry, J. P. Elevated serum levels of tumor marker CA19-9 in acute cholangitis. Dig. Dis. Sci. 1988, 33, 1223-1225.
7. Rosty, C.; Goggins, M. Early detection of pancreatic carcinoma. Hematol. Oncol. Clin. North Am. 2002, 16, 37-52.
8. Ching, C. K.; Rhodes, J. M. Enzyme-linked PNA lectin binding assay compared with CA19-9 and CEA radioimmunoassay as a diagnostic blood test for pancreatic cancer. Br. J. Cancer 1989, 59, 949953.
9. Uehara, H.; Nakaizumi, A.; Tatsuta, M.; Baba, M.; Takenaka, A.; Uedo, N.; Sakai, N.; Yano, H.; Iishi, H.; Ohigashi, H.; Ishikawa, O.; Okada, S.; Kakizoe, T. Diagnosis of pancreatic cancer by detecting telomerase activity in pancreatic juice: comparison with K-ras mutations. Am. J. Gastroenterol. 1999, 94, 2513-2518.
10. Yokoyama, M.; Ochi, K.; Ichimura, M.; Mizushima, T.; Shinji, T.; Koide, N.; Tsurumi, T.; Hasuoka, H.; Harada, M. Matrix metallo-proteinase-2 in pancreatic juice for diagnosis of pancreatic cancer. Pancreas 2002, 24, 344-347.
11. Yu, K. H.; Rustgi, A. K.; Blair, I. A. Characterization of proteins in human pancreatic cancer serum using differential gel electro-phoresis and tandem mass spectrometry. J. Proteome Res. 2005, 4, 1742-1751.
12. Yocum, A. K.; Yu, K.; Oe, T.; Blair, I. A. Effect of immunoaffinity depletion of human serum during proteomic investigations. L. Proteome Res. 2005, 4, 1722-1731.
13. Yan, Y.; Weaver, V. M.; Blair, I. A. Analysis of protein expression during oxidative stress in breast epithelial cells using a stable isotope labeled proteome internal standard. L. Proteome Res. 2005, 4, 2007-2014.
14. Yocum, A. K.; Busch, C. M.; Felix, C. A.; Blair, I. A. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations. J. Proteome Res. 2006, 5, 2743-2753.
15. Oe, T.; Ackermann, B. L.; Inoue, K.; Berna, M. J.; Garner, C. O.; Gelfanova, V.; Dean, R. A.; Siemers, E. R.; Holtzman, D. M.; Farlow, M. R.; Blair, I. A. Quantitative analysis of amyloid beta peptides in cerebrospinal fluid of Alzheimer's disease patients by immu-noaffinity purification and stable isotope dilution liquid chroma-tography/negative electrospray ionization tandem mass spectrometry. Rapid Commun. Mass Spectrom. 2006, 20, 3723-3735.
16. Yocum, A. K.; Yu, K.; Oe, T.; Blair, I. A. Effect of immunoaffinity depletion of human serum during proteomic investigations. J Proteome Res. 2005, 4, 1722-1731.
17. Anderson, L. Candidate-based proteomics in the search for biom-arkers of cardiovascular disease. J. Physiol. 2005, 563, 23-60.
18. Everley, P. A.; Bakalarski, C. E.; Elias, J. E.; Waghorne, C. G.;Beausoleil, S. A.; Gerber, S. A.; Faherty, B. K.; Zetter, B. R.; Gygi, S. P. Enhanced analysis of metastatic prostate cancer using stable isotopes and high mass accuracy instrumentation. J. Proteome Res. 2006, 5, 1224-1231.
19. Cargile, B. J.; Sevinsky, J. R.; Essader, A. S.; Stephenson, J. L., Jr.; Bundy, J. L. Immobilized pH gradient isoelectric focusing as a first-dimension separation in shotgun proteomics. J. Biomol. Tech. 2005, 16, 181-189.
20. Liu, T.; Qian, W. J.; Gritsenko, M. A.; Xiao, W.; Moldawer, L. L.; Kaushal, A.; Monroe, M. E.; Varnum, S. M.; Moore, R. J.; Purvine, S. O.; Maier, R. V.; Davis, R. W.; Tompkins, R. G.; Camp, D. G.; Smith, R. D. High dynamic range characterization of the trauma patient plasma proteome. Mol. Cell. Proteomics 2006, 5,1899-1913.
21. Yocum, A. K.; Yu, K.; Oe, T.; Blair, I. A. Effect of immunoaffinity depletion of human serum during proteomic investigations. J Proteome Res. 2005, 4, 1722-1731.
22. Janini, G. M.; Conrads, T. P.; Veenstra, T. D.; Issaq, H. J. Development of a two-dimensional protein-peptide separation protocol for comprehensive proteome measurements. J. Chromatogr., B: Analyt. Technol. Biomed. Life Sci. 2003, 787, 43-51.
23. Michel, P. E.; Crettaz, D.; Morier, P.; Heller, M.; Gallot, D.; Tissot, J. D.; Reymond, F.; Rossier, J. S. Proteome analysis of human plasma and amniotic fluid by Off-Gel isoelectric focusing followed by nano-LC-MS/MS. Electrophoresis 2006, 27, 1169-1181.
24. Tang, H. Y.; li-Khan, N.; Echan, L. A.; Levenkova, N.; Rux, J. J.; Speicher, D. W. A novel four-dimensional strategy combining protein and peptide separation methods enables detection oflow-abundance proteins in human plasma and serum proteomes. Proteomics 2005, 5, 3329-3342.
25. Sabounchi-Schutt, F.; Astrom, J.; Olsson, I.; Eklund, A.; Grunewald, J.; Bjellqvist, B. An immobiline DryStrip application method enabling high-capacity two-dimensional gel electrophoresis. Electrophoresis 2000, 21, 3649-3656.
26. Ong, S. E.; Blagoev, B.; Kratchmarova, I.; Kristensen, D. B.; Steen, H.; Pandey, A.; Mann, M. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
27. Yan, Y.; Weaver, V. M.; Blair, I. A. Analysis of protein expressiond uring oxidative stress in breast epithelial cells using a stable isotope labeled proteome internal standard. J. Proteome Res. 2005, 4, 2007-2014.
28. Yocum, A. K.; Busch, C. M.; Felix, C. A.; Blair, I. A. Proteomics-based strategy to identify biomarkers and pharmacological targets in leukemias with t(4;11) translocations. J. Proteome Res. 2006, 5, 2743-2753.
29. Han, D. K.; Eng, J.; Zhou, H.; Aebersold, R. Quantitative profiling of differentiation-induced microsomal proteins using isotope-coded affinity tags and mass spectrometry. Nat. Biotechnol. 2001, 19, 946-51.
30. Kanehisa, M.; Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000, 28, 27-30.
31. Apweiler, R.; Bairoch, A.; Wu, C. H.; Barker, W. C.; Boeckmann, B.; Ferro, S.; Gasteiger, E.; Huang, H.; Lopez, R.; Magrane, M.; Martin, M. J.; Natale, D. A.; O'Donovan, C.; Redaschi, N.; Yeh, L. S. UniProt: the Universal Protein knowledgebase. Nucleic Acids Res. 2004, 32, D115-D119.
32. Chen, R.; Yi, E. C.; Donohoe, S.; Pan, S.; Eng, J.; Cooke, K.; Crispin, D. A.; Lane, Z.; Goodlett, D. R.; Bronner, M. P.; Aebersold, R.; Brentnall, T. A. Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape. Gastro-enterology 2005, 129, 1187-1197.
33. Caulin, C.; Salvesen, G. S.; Oshima, R. G. Caspase cleavage of keratin 18 and reorganization of intermediate filaments during epithelial cell apoptosis. J. Cell Biol. 1997, 138, 1379-1394.
34. Ku, N. O.; Liao, J.; Omary, M. B. Apoptosis generates stable fragments of human type I keratins. J. Biol. Chem. 1997, 272, 33197-33203.
35. Hosokawa, M.; Kashiwaya, K.; Eguchi, H.; Ohigashi, H.; Ishikawa, O.; Furihata, M.; Shinomura, Y.; Imai, K.; Nakamura, Y.; Nakagawa, H. Over-expression of cysteine proteinase inhibitor cystatin 6 promotes pancreatic cancer growth. Cancer Sci. 2008, 99, 16261632.
36. Lipponen, P.; Aaltomaa, S.; Kosma, V. M.; Syrjanen, K. Apoptosis in breast cancer as related to histopathological characteristics and prognosis. Eur. J. Cancer 1994, 30A, 2068-2073.
37. Berardo, M. D.; Elledge, R. M.; de Moor, C.; Clark, G. M.; Osborne, C. K.; Allred, D. C. bcl-2 and apoptosis in lymph node positive breast carcinoma. Cancer 1998, 82, 1296-1302.
38. Zhang, G. J.; Kimijima, I.; Abe, R.; Watanabe, T.; Kanno, M.; Hara, K.; Tsuchiya, A. Apoptotic index correlates to bcl-2 and p53 protein expression, histological grade and prognosis in invasive breast cancers. Anticancer Res. 1998, 18, 1989-1998.
39. Kramer, G.; Erdal, H.; Mertens, H. J.; Nap, M.; Mauermann, J.; Steiner, G.; Marberger, M.; Biven, K.; Shoshan, M. C.; Linder, S. Differentiation between cell death modes using measurements of different soluble forms of extracellular cytokeratin 18. Cancer Res. 2004, 64, 1751-1756.
40. Ueno, T.; Toi, M.; Biven, K.; Bando, H.; Ogawa, T.; Linder, S. Measurement of an apoptotic product in the sera of breast cancer patients. Eur. J. Cancer 2003, 39, 769-774.
41. Ley, K.; Laudanna, C.; Cybulsky, M. I.; Nourshargh, S. Getting to the site of inflammation: the leukocyte adhesion cascade updated. Nat. Rev. Immunol. 2007, 7, 678-689.
42. Maatta, M.; Butzow, R.; Luostarinen, J.; Petajaniemi, N.; Pihlajani-emi, T.; Salo, S.; Miyazaki, K.; Autio-Harmainen, H.; Virtanen, I. Differential expression of laminin isoforms in ovarian epithelial carcinomas suggesting different origin and providing tools for differential diagnosis. J. Histochem. Cytochem. 2005, 53, 1293-1300.
43. Schon, M.; Klein, C. E.; Hogenkamp, V.; Kaufmann, R.; Wienrich, B. G.; Schon, M. P. Basal-cell adhesion molecule (B-CAM) is induced in epithelial skin tumors and inflammatory epidermis, and is expressed at cell-cell and cell-substrate contact sites. J. Invest Dermatol. 2000, 115, 1047-1053.
44. Kikkawa, Y.; Miner, J. H. Review: Lutheran/B-CAM: a laminin receptor on red blood cells and in various tissues. Connect. Tissue Res. 2005, 46, 193-199.
45. Campbell, I. G.; Foulkes, W. D.; Senger, G.; Trowsdale, J.; Garin-Chesa, P.; Rettig, W. J. Molecular cloning of the B-CAM cell surface glycoprotein of epithelial cancers: a novel member of the immu-noglobulin superfamily. Cancer Res. 1994, 54, 5761-5765.
46. Lehmann, J. M.; Riethmuller, G.; Johnson, J. P. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immuno-globulin superfamily. Proc. Natl. Acad. Sci. U.S.A. 1989, 86, 98919895.
47. Keshishian, H.; Addona, T.; Burgess, M.; Kuhn, E.; Carr, S. A. Quantitative, multiplexed assays for low abundance proteins in plasma by targeted mass spectrometry and stable isotope dilution. Mol. Cell. Proteomics 2007, 6, 2212-2229. PR800904Z